Related Experiment Videos
Response to subcutaneous therapy with mistletoe in recurrent multisystem Langerhans cell histiocytosis
Georg Seifert1, Alfred Laengler, Christoph Tautz
1Department of Pediatric Oncology/Hematology, Otto-Heubner-Center for Pediatric and Adolescent Medicine, Charité-Universitätsmedizin Berlin, Germany. georg.seifert@charite.de
Pediatric Blood & Cancer
|November 2, 2005
Abstract:
We report a case of histologically proven multisystem (MS) Langerhans cell histiocytosis (LCH) with recurrent disease reactivations after systemic chemotherapy. Through the use of subcutaneous therapy with mistletoe (MT), an inactive disease state was achieved.